Software

Descartes Systems is still undervalued, says Industrial Alliance

Descartes Systems Group’s (TSX:DSG, Nasdaq:DSGX) upcoming fourth quarter results should demonstrate stability and investors should take advantage of a recent pullback in the company’s share price to buy the stock, says Industrial Alliance Securities analyst Blair Abernethy.
On Thursday, March 3, Descartes will report its 2016 fourth quarter and annual results.
Abernethy says he is expecting Descartes will post EBITDA of $16-million on revenue of $48.3-million in the fourth quarter, numbers that are in-line with the street consensus.
The Industrial Alliance analyst says he will be watching for how Descartes mid-quarter acquisition of Oz Development strengthens its existing relationships with Netsuite and UPS. He says he is also keen to learn of progress on the partnership front, particularly with long-time partner SAP. And he says he will be scrutinizing forex headwinds, which he says have been a challenge for the Waterloo-based company, but one he expects to abate as 2016 moves on.
Descartes closed at a 52-week high of more than (U.S.) $20.00 to close 2015 to current prices under $17.00. Abernethy says the current price of Descartes represents a good entry point for investors.
“We would continue to be buyers of the stock ahead of the quarterly results, given the recent pullback in the stock from ~$20.00, the stability of its business model, and the history of resilient operational performance in the face of weak macro environments,” he says.
In a research update to clients yesterday, Abernethy maintained his “Buy” rating and one-year price target of (U.S.) $21.00 on Descartes Systems Group, implying a return of 28.4 per cent at the time of publication.

Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Ambarella wins price target raise at Roth

Roth Capital Markets analyst Suji Desilva raised his price target for Ambarella (Ambarella Stock Quote, Chart, News, Analysts, Financials NASDAQ:AMBA)… [Read More]

8 hours ago

Novo Nordisk is undervalued, this fund manager says

Darren Sissons, partner and portfolio manager at Campbell, Lee & Ross Investment Management, told BNN Bloomberg’s Market Call on Aug.… [Read More]

8 hours ago

The risk-to-return on NTG Clarity Networks is incredible, Beacon Securities says

Beacon Securities analyst Doug Cooper maintained a “Buy” rating and $5.00 target for NTG Clarity Networks (NTG Clarity Networks Stock… [Read More]

9 hours ago

NervGen Pharma price target chopped at Research Capital

Research Capital analyst Andre Uddin lowered his target price for NervGen Pharma (NervGen Pharma Stock Quote, Chart, News, Analysts, Financials… [Read More]

9 hours ago

Theralase Technologies is very undervalued, this analyst says

Research Capital analyst Andre Uddin maintained a “Speculative buy” rating and C$0.70 target price on Theralase Technologies (Theralase Technologies Stock… [Read More]

9 hours ago

Sabio Q2 gets thumbs up at Paradigm Capital

Paradigm Capital analyst Daniel Rosenberg reiterated a “Buy” rating and C$1.50 target price on Sabio Holdings (Sabio Holdings Stock Quote,… [Read More]

4 days ago